• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Agilent Technologies prepares for IPO

Article

Newly spun-off Hewlett-Packard healthcare operation Agilent Technologies has filed a registration statement with the Securities and Exchange Commission for a proposed public offering, the company has announced. Agilent will offer 57 million shares of

Newly spun-off Hewlett-Packard healthcare operation Agilent Technologies has filed a registration statement with the Securities and Exchange Commission for a proposed public offering, the company has announced. Agilent will offer 57 million shares of common stock, 45.6 million offered in the U.S. and Canada, and 11.4 million of which will be offered internationally. Estimated IPO price per share is between $19 and $22, according to Agilent. Morgan Stanley Dean Witter and Goldman, Sachs & Company are handling the offering.

In March, Palo Alto, CA-based Hewlett-Packard spun off its medical products group, along with four other businesses, in an effort to focus on its computer business (SCAN 3/17/99). The name Agilent Technologies was chosen for the $8 billion Andover, MA, company in August (SCAN 8/4/99).

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.